Results 151 to 160 of about 13,627,543 (246)

Arginine methylation as a regulatory ratchet in cancer: From substrate selection to malignant‐state stabilization

Molecular Oncology, EarlyView.
Arginine methylation can be viewed as a persistence‐prone post‐translational modification regulated by a network of PRMTs. Competitive and compensatory interactions among PRMTs can redistribute methylation across substrate pools shaped by sequence, structural, spatial, and environmental layers, reinforcing RNA‐processing, chromatin, and signaling ...
So Hyun Kwon, Ji Min Lee
wiley   +1 more source

Does the Dutch trial prove we should “say no” to active surveillance? An in-depth review of the 2025 study on the treatment of esophageal cancerCentral MessagePerspective

JTCVS Open
Brian N. Housman, MD, Stephanie Tuminello, PhD, MPH, Raja Flores, MD   +2 more
doaj   +1 more source

Reply to the Comment on the Article "Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor Based Combination Therapy for Unresectable Hepatocellular Carcinoma". [PDF]

Liver Cancer
Huang ZH, Huang JL, Lin LP, Yang DL, Ma L, Zhong JH, GUIDANCE Investigators.   +6 more
europepmc   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Reply to "Methodological Concerns in 'Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma'". [PDF]

Liver Cancer
Yang DL, Huang JL, Qin HG, Ma L, Zhong JH, GUIDANCE Investigators.   +5 more
europepmc   +1 more source

Clinical feasibility of the therapeutic strategies total neoadjuvant therapy and "watch and wait" in the treatment of rectal cancer patients with recurrence after clinical complete response. [PDF]

Front Surg, 2022
Dai D, Liu G, Liu H, Liu Y, Liu X, Li S, Lei Y, Gao Y, Wang Y, Zhang S, Zhang R.   +10 more
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Connecticut State Emergency Response Commission [web site] [Harvested on 2012: Aug. 10]

, 2012
Updated irregularly; Began in 2002?; Title from home page (publisher's Web site, viewed June 1, 2011).; At head of title: State of Connecticut.; Official website of the Connecticut State Emergency Response Commission.

core  

Organ preservation in rectal cancer following clinical complete response after short-course radiotherapy-based total neoadjuvant therapy. [PDF]

Clin Transl Radiat Oncol
Morales CG, Manriquez-Alegria E, Duran V, Gonzalez M, Carvajal G, Briones P, Mena F, Quintana M, Castillo R, Fulle A, Cabreras M, Kusanovich R, Caire N, Retamales J, García P, Muñoz-Salazar D, Quezada-Díaz FF.   +16 more
europepmc   +1 more source

Watch-and-wait Management for Rectal Cancer After Clinical Complete Response to Neoadjuvant Therapy. [PDF]

Adv Surg, 2021
Yuval JB, Garcia-Aguilar J.
europepmc   +1 more source